2. Antibody-drug Conjugate/ADC Related Metabolic Enzyme/Protease
  3. Radionuclide-Drug Conjugates (RDCs) Carbonic Anhydrase
  4. DPI-4452

DPI-4452 is a CAIX-targeting cyclic peptide with a DOTA cage, and can be chelated with radionuclide for CAIX-expressing tumor PET-CT imaging and study. DPI-4452 specifically and selectively binds CAIX without interaction with an in vitro off-target receptor panel of 55 targets (IC50 for recombinant hCAIX: 130?nM). Radiolabeled DPI-4452 inhibits tumor growth in HT-29 and SK-RC-52 xenograft mouse models. DPI-4452 can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).

For research use only. We do not sell to patients.

Custom Peptide Synthesis

DPI-4452 Chemical Structure

DPI-4452 Chemical Structure

CAS No. : 2941391-49-5

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

DPI-4452 Related Antibodies

Top Publications Citing Use of Products

View All Radionuclide-Drug Conjugates (RDCs) Isoform Specific Products:

View All Isoforms
RDC Peptide RDC Antibody RDC Bifunctional Chelator RDC Linker Other

View All Carbonic Anhydrase Isoform Specific Products:

View All Isoforms
CA CA I CA Ⅱ CA Ⅸ CA XII

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

DPI-4452 is a CAIX-targeting cyclic peptide with a DOTA cage, and can be chelated with radionuclide for CAIX-expressing tumor PET-CT imaging and study. DPI-4452 specifically and selectively binds CAIX without interaction with an in vitro off-target receptor panel of 55 targets (IC50 for recombinant hCAIX: 130?nM). Radiolabeled DPI-4452 inhibits tumor growth in HT-29 and SK-RC-52 xenograft mouse models[1]. DPI-4452 can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).

IC50 & Target[1]

hCA IX

0.25 nM (Kd)

In Vitro

DPI-4452 (with or without chelating lutetium or gallium ions) binds potently and specifically to CAIX with minimal internalization without interaction with an in vitro off-target receptor panel of 55 targets[1].
DPI-4452 (111In-labeled, 8 h) has a similar affinity for Chinese hamster ovary cells expressing hCAIX and cCAIX, markedly higher than that of Chinese hamster ovary cells expressing mCAIX (KD: 0.3 and 63 nM, respectively)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

DPI-4452 Related Antibodies
In Vivo

DPI-4452 is rapidly eliminated in mice (0.7-5.5 mg/kg, i.v., single) and dogs (0.1 mg/kg, i.v., single)[1].
DPI-4452 ([177Lu]Lu-labeled, single doses of 100 MBq or 3 once-weekly 33 MBq doses, i.v.) reduces tumor burden in HT-29 and SK-RC-52 human xenograft mouse models[1].
DPI-4452 ([111In]In-labeled, 30 MBq, i.v.) exhibits high tumor uptake in the HT-29 CRC and SK-RC-52 ccRCC xenograft tumor mouse models[1].
DPI-4452 mass dose (2.5-22.5  μg/kg) does not affect uptake in healthy tissues in the tested dose range in Beagle dogs[1].
Mean Plasma Pharmacokinetics of DPI-4452 After Single Injection of DPI-4452 in Beagle Dogs

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Administration Dose (mg/kg) Sex C5 min (ng/mL) tlast (h) AUCinf (h × ng/mL)
i.v. 0.016 Female 37.7 (6.83) 1 (1-1) 12.4 (2.13)
i.v. 0.016 Male 43.5 (2.75) 1 (1-1) 14 (1.29)
i.v. 0.08 Female 346 (34.8) 3 (2-3) 144 (15.3)
i.v. 0.08 Male 332 (14.7) 2 (2-3) 132 (5.49)
i.v. 0.4 Female 1760 (180) 3 (3-3) 771 (40.6)
i.v. 0.4 Male 1840 (257) 3 (3-3) 854 (120)
Animal Model: HT-29 and SK-RC-52 human xenograft mouse models (2-5 × 106)[1]
Dosage: [177Lu]Lu-labeled DPI-4452, 100 MBq, single doses; 3 once-weekly 33 MBq doses
Administration: Intravenous injection (i.v.)
Result: Both 100-MBq and three weekly doses of 33-MBq produced maximum tumor growth inhibition in HT-29 xenografts and SK-RC-52 xenografts on days 23 and 36, respectively.
Showed no significant difference in tumor size in SK-RC-52 xenografts at day 36 after treatment with a single 100-MBq or 33-MBq doses.
Molecular Weight

2106.36

Formula

C92H132N22O29S3
CAS No.
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

DPI-4452 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

DPI-44522941391-49-5DPI4452DPI 4452Radionuclide-Drug Conjugates (RDCs)Carbonic AnhydraseCarbonate dehydrataseHT-29SK-RC-52xenograftsRadioactivityBurdenAntitumorInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
DPI-4452
Cat. No.:
HY-P10761
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (0 KB) Français - FR (0 KB) Deutsch - DE (0 KB) Norwegian - NO (0 KB) Español - ES (0 KB) Swedish - SV (0 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.